Mark Gruszynski, MD
Plastic and Reconstructive Surgery · Scottsdale, AZNPI 1396188033
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,434 and has fallen 76.1% since, to $342 in 2025.
Across 73 payments — averaging $54.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$848
- Sientra, Inc.$564
- Davol Inc.$543
- Galderma Laboratories, L.p.$294
- AbbVie$287
- Trice Medical, Inc.$267
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,945100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 6 | $848 |
| Sientra, Inc. | 9 | $564 |
| Davol Inc. | 8 | $543 |
| Galderma Laboratories, L.p. | 7 | $294 |
| AbbVie | 13 | $287 |
| Trice Medical, Inc. | 4 | $267 |
| Mentor Worldwide LLC | 8 | $198 |
| Stryker | 1 | $197 |
| Sanara Medtech Inc. | 1 | $140 |
| Revance Therapeutics, Inc. | 1 | $130 |
| Sun Pharmaceutical Industries Inc. | 4 | $90 |
| Dilon Technologies, Inc. | 1 | $90 |
| Axogen | 1 | $76 |
| Sanofi | 2 | $55 |
| Organogenesis Inc. | 2 | $50 |
| Integra Lifesciences Corporation | 1 | $34 |
| Amgen | 1 | $25 |
| Surgenex LLC | 1 | $25 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $17 |
| Sandoz | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,945 in reported general payments places this provider in the 60th percentile of 63 plastic and reconstructive surgery providers in Arizona.
See all plastic and reconstructive surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 20 | $167 |
| Cephalexin | 18 | $126 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Scottsdale
- Richard BrownScottsdale$12K
- Lawrence ShawScottsdale$9K
- Sergey TurinScottsdale$9K
- Ryan TsujimuraScottsdale$8K
- Eleazar Ley TaiScottsdale$6K
- Robert BonillasScottsdale$6K
- Enrique LeonScottsdale$5K
- Ethan PhilpottScottsdale$4K
- John PierceScottsdale$3K
- Jennifer GeogheganScottsdale$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.